El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Revenue
Revenue
EGP 2.24B
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2025 | 1.29B | 12.86% |
| 2024 | 1.14B | 13.67% |
| 2023 | 1.01B | 14.65% |
| 2022 | 876.78M | 16.05% |
| 2021 | 755.51M | -7.02% |
| 2020 | 812.54M | 27.3% |
| 2019 | 638.27M | 38.78% |
| 2018 | 459.93M | 10.1% |
| 2017 | 417.74M | 26.41% |
| 2016 | 330.46M | 14.96% |
| 2015 | 287.46M | -12.91% |
| 2014 | 330.08M | -6.14% |
| 2013 | 351.69M | 2.6% |
| 2012 | 342.79M | 1.47% |
| 2011 | 337.81M | -1.07% |
| 2010 | 341.46M | 2.97% |
| 2009 | 331.61M | 4.68% |
| 2008 | 316.77M | -5.09% |
| 2007 | 333.74M | 9.73% |
| 2006 | 304.16M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.